First Time Loading...

ChemoCentryx Inc
NASDAQ:CCXI

Watchlist Manager
ChemoCentryx Inc Logo
ChemoCentryx Inc
NASDAQ:CCXI
Watchlist
Price: 51.99 USD Market Closed
Updated: May 21, 2024

Balance Sheet

Balance Sheet Decomposition
ChemoCentryx Inc

Current Assets 345.2m
Cash & Short-Term Investments 328.6m
Receivables 4.9m
Other Current Assets 11.6m
Non-Current Assets 74.2m
Long-Term Investments 17.6m
PP&E 55.2m
Other Non-Current Assets 1.5m
Current Liabilities 76.1m
Accounts Payable 7.6m
Accrued Liabilities 27.7m
Other Current Liabilities 40.7m
Non-Current Liabilities 106.8m
Long-Term Debt 4m
Other Non-Current Liabilities 102.8m

Balance Sheet
ChemoCentryx Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021
Assets
Cash & Cash Equivalents
9
10
16
13
12
40
28
39
32
50
Cash Equivalents
9
10
16
13
12
40
28
39
32
50
Short-Term Investments
94
123
57
59
106
87
149
134
404
215
Total Receivables
1
0
0
0
30
51
2
0
0
0
Accounts Receivables
1
0
0
0
30
51
2
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
0
1
Other Current Assets
1
1
1
1
1
1
2
1
5
3
Total Current Assets
105
134
74
72
149
180
181
174
442
269
PP&E Net
1
1
1
1
1
1
2
4
52
57
PP&E Gross
1
1
1
1
1
1
2
4
52
57
Accumulated Depreciation
6
7
7
8
8
8
8
9
7
9
Long-Term Investments
16
17
41
5
6
8
0
30
24
98
Other Long-Term Assets
0
0
0
0
0
0
0
1
2
2
Total Assets
122
N/A
152
+25%
117
-23%
78
-33%
156
+99%
189
+21%
183
-3%
209
+14%
519
+148%
426
-18%
Liabilities
Accounts Payable
1
1
1
1
1
1
1
2
13
7
Accrued Liabilities
6
6
7
4
8
8
12
19
20
26
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
1
0
0
0
0
0
0
0
6
19
Other Current Liabilities
4
0
0
1
29
24
51
39
13
11
Total Current Liabilities
11
7
8
6
38
33
64
59
52
63
Long-Term Debt
0
0
0
0
0
5
20
20
18
5
Other Liabilities
0
0
0
0
68
72
85
64
64
72
Total Liabilities
12
N/A
7
-41%
8
+18%
6
-33%
106
+1 793%
110
+4%
169
+53%
143
-15%
133
-7%
140
+5%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
134
173
220
267
307
289
375
430
485
617
Additional Paid In Capital
245
318
328
340
357
369
389
496
871
904
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
110
N/A
145
+32%
109
-25%
73
-33%
50
-31%
79
+59%
15
-81%
66
+349%
386
+484%
286
-26%
Total Liabilities & Equity
122
N/A
152
+25%
117
-23%
78
-33%
156
+99%
189
+21%
183
-3%
209
+14%
519
+148%
426
-18%
Shares Outstanding
Common Shares Outstanding
36
43
43
44
48
49
51
60
70
70

See Also

Discover More